The effect of proton pump inhibitor and potassium competitive acid blocker toward endothelial cells.
Not Applicable
- Conditions
- healthy adults
- Registration Number
- JPRN-UMIN000024875
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
current smoker HbA1Cis over 6.5 BMIis over 30 Those who take other drugs. Those who have the history of hypertension, atherosclerosis. Those who are not allowed by research doctors.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method We evaluate how PPI and PCAB effect to endothelial cells after 8week medication by measuring ADMA and FMD.
- Secondary Outcome Measures
Name Time Method